Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€51.04

€51.04

-0.040%
-0.02
-0.040%
€56.83
 
08.12.23 / Tradegate WKN: 884113 / Symbol: BSX / Name: Boston Scient / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Boston Scientific Stock

There is nearly no change for the Boston Scientific stock today. Compared to yesterday it only changed by -€0.020.
With 18 Buy predictions and not the single Sell prediction the community is currently very high on Boston Scientific.
With a target price of 56 € there is a slightly positive potential of 9.72% for Boston Scientific compared to the current price of 51.04 €.
So far the community has only identified positive things for Boston Scientific stock. The most positive votes were given for criterium "Valuation (undervalued/overvalued)".

Pros and Cons of Boston Scientific in the next few years

Pros
?
B****
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Boston Scientific vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Boston Scientific -0.040% -1.085% 4.870% 16.277% 17.943% 81.896% 58.215%
QuidelOrtho Corp. 0.640% -3.379% 9.737% -30.994% -22.314% -61.877% -
Illumina Inc. -3.300% 4.004% 1.529% -47.346% -43.924% -62.945% -62.481%
Waters Corp. 0.000% 2.256% 13.333% -16.230% -15.685% 39.487% 60.804%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-06-15

Boston Scientific Corporation (NYSE: BSX) is a prominent player in the healthcare equipment and supplies industry. A review of its financial statements in recent years paints an interesting picture of the company's growth and stability. Initially, it seems that Boston Scientific has experienced a robust increase in total assets and revenue, as indicated in the balance sheet and income statements, which is generally a positive sign for any business. However, a detailed analysis of the company's financials is necessary to better understand its financial health and identify any possible concerns.

*Pros: *

Growth in Total Assets and Total Revenue: Boston Scientific's total assets have been consistently growing year-over-year since 2020, and its total revenue increased from €9.91 billion in 2020 to $12.68 billion in 2022. This growth is indicative of the company's ability to generate business in its niche market and points to a healthy expansion of its operations.

Comments

Prediction Buy
Perf. (%) 0.16%
Target price 56.297
Change
Ends at 04.12.24

Boston Scientific Co. (NYSE: BSX) had its price target raised by analysts at Morgan Stanley from $58.00 to $61.00. They now have an "overweight" rating on the stock.
Ratings data for BSX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 8.92%
Target price 56.826
Change
Ends at 27.10.24

Boston Scientific Co. (NYSE: BSX) had its price target lowered by analysts at Needham & Company LLC from $65.00 to $60.00. They now have a "buy" rating on the stock.
Ratings data for BSX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 0.55%
Target price 57.163
Change
Ends at 21.09.24

Boston Scientific Co. (NYSE: BSX) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $61.00 price target on the stock.
Ratings data for BSX provided by MarketBeat
Show more